The trials of Dr. Bernard Fisher: A European perspective on an American episode

Controlled Clinical Trials

Volumn 18, Issue 1, 1997, Pages 1-13

  Peto, Richard ^a,b,j   Collins, Rory ^a,b   Sackett, David ^b   Darbyshire, Janet ^c   Babiker, Abdel ^c   Buyse, Marc ^d   Stewart, Helen ^e   Baum, Michael ^f   Goldhirsch, Aron ^g   Bonadonna, Gianni ^h   Valagussa, Pinuccia ^h   Rutqvist, Lars ⁱ   Elbourne, Diana ^j   Davies, Christina ^a   Dalesio, Otilia ^k   Parmar, Mahesh ^c   Hill, Catherine ^l   Clarke, Michael ^a,b   Gray, Richard ^a,b   Doll, Richard ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g Ospedale Civico Lugano   (Switzerland)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j RADCLIFFE INFIRMARY   (United Kingdom)

^k NETHERLANDS CANCER INSTITUTE   (Netherlands)

^l INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; CLINICAL TRIAL; EUROPE; HUMAN; UNITED STATES;

BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EUROPE; FEMALE; HISTORY, 20TH CENTURY; HUMANS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; UNITED STATES;

EID: 0031080724     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00225-5     Document Type: Article

References (13)

1. 1. Collins R, Peto R, Gray R, Parish S. (1996) Large-scale randomized evidence: trials and overviews. In: Weatherall D, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine (3rd edition) Vol I. New York: Oxford University Press; 1996:21-32.
2. 2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339:1-15, 71-85.
3. 3. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
4. 4. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461.
5. 5. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995;333:1444-1455.
6. 6. Christian MC, McCabe MS, Korn EL, et al. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project protocol B-06. N Engl J Med 1995;333:1469-1474.
7. 7. Sheikh L. Case study: breast cancer research fraud. 1995 report to Center for Health Communications. Boston: Harvard School of Public Health.
8. 8. Rennie D. Breast cancer: how to mishandle misconduct. JAMA 1994;271:1205-1207.
9. 9. Angell M, Kassirer JP. Setting the record straight in the breast cancer trials. N Engl J Med 1994;330:1448-1450.
10. 10. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-537.
11. 11. Fisher B. A commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients. J Clin Oncol 1996;14:1027-1039.
12. 12. Fisher B, Redmond CK. Fraud in breast cancer trials. N Engl J Med 1994;330: 1458-1460.
13. 13. Healy B. The Dangers of Trial by Dingell. N Y Times July 3, 1996;